Like CD8+ T cells, Tregs also infiltrate the tumor stroma and a low CD8+ T cells to Tregs ratio is a poor indicator of disease outcome, overall survival and treatment outcomes in ovarian [92], breast [93] and bladder cancers [94]. The gene discussed is CD8A; the disease is urinary bladder cancer.